Circulating interferon‐α measured with a highly sensitive assay as a biomarker for juvenile inflammatory myositis activity.
ARTHRITIS & RHEUMATOLOGY | SEPTEMBER 05, 2019
Melki I, Devilliers H, Gitiaux C, Bondet V, Belot A, Bodemer C, Quartier P, Crow YJ, Duffy D, Rodero MP and Bader Meunier B
Arthritis Rheumatol. 2019 Sep 5. doi: 10.1002/art.41096.
We read with interest the study of Mathian et al (1), suggesting that direct serum IFNα determination with a highly sensitive assay might be useful for disease activity monitoring in systemic lupus erythematosus (SLE). More generally, the identification of reactive biomarkers is highly desirable in many disease states, including idiopathic inflammatory myositis (IIM). This article is protected by copyright. All rights reserved.
Share this page